For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Keurig Dr Pepper Inc. (KDP) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Watch · Gem Score -5 (−100…+100 Quality+Value blend) · Quality 21 · Value -27 · Sentiment 4 (timing only, not weighted) · Composite fair value $34.11 vs $32.04 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Keurig Dr Pepper Inc.
KDP NASDAQKeurig Dr Pepper Inc. is a leading North American beverage company that manufactures, markets, and distributes a broad portfolio of non-alcoholic drinks. The company focuses on two primary areas: packaged beverages and coffee systems. Its refreshment beverages segment includes well-known soft drink, water, juice, and mixer brands such as Dr Pepper, Canada Dry, Snapple, Mott’s, Bai, CORE Hydration, and various energy and flavored drink lines. In coffee, Keurig Dr Pepper develops single-serve brewing systems and coffee pods under the Keurig and Green Mountain Coffee Roasters brands, along with numerous licensed partner brands. The company serves retailers, foodservice operators, and consumers across the United States, Canada, Mexico, and select international markets through extensive manufacturing and distribution networks. Founded in 2018 and headquartered in Burlington, Massachusetts, Keurig Dr Pepper plays a significant role in the consumer staples sector as a major provider of both hot and cold beverage solutions.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.53
Total Equity: $25.52B
Shares: 1,362,800,000
Total Debt: $16.14B
Cash: $1.03B
EBITDA: $4.17B
Total Debt: $16.14B
Cash: $1.03B
Revenue: $16.60B
Revenue: $16.60B
Revenue: $16.60B
Total Equity: $25.52B
Tax Rate: 22.6%
Equity: $25.52B
Total Debt: $16.14B
Cash: $1.03B
Current Liabilities: $8.29B
Long-Term Debt: $13.04B
Total Debt: $16.14B
Total Equity: $25.52B
Shares: 1,362,800,000
Shares: 1,362,800,000
CapEx: -$486.00M
Shares: 1,362,800,000
Stock Price: $32.04
Net Income: $2.08B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 22, 2026 3:47pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $12.7B | $14.1B | $14.8B | $15.4B | $16.6B |
| Cost of Revenue | $5.7B | $6.7B | $6.7B | $6.8B | $7.6B |
| Gross Profit | $7.0B | $7.3B | $8.1B | $8.5B | $9.0B |
| Operating Expenses | $4.1B | $4.7B | $4.9B | $5.9B | $5.4B |
| Operating Income | $2.9B | $2.6B | $3.2B | $2.6B | $3.6B |
| Net Income | $2.1B | $1.4B | $2.2B | $1.4B | $2.1B |
| EBITDA | $3.4B | $3.1B | $3.7B | $3.1B | $4.2B |
| EPS | $1.52 | $1.01 | $1.56 | $1.06 | $1.53 |
| EPS (Diluted) | $1.50 | $1.01 | $1.55 | $1.05 | $1.53 |
Balance Sheet (Annual)
Last updated: Aug 22, 2026 3:29pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $567.0M | $535.0M | $267.0M | $510.0M | $1.0B |
| Total Current Assets | $3.1B | $3.8B | $3.4B | $4.0B | $5.3B |
| Total Assets | $50.6B | $51.8B | $52.1B | $53.4B | $55.5B |
| Current Liabilities | $6.5B | $8.1B | $8.9B | $8.1B | $8.3B |
| Long-Term Debt | $11.6B | $11.1B | $9.9B | $12.9B | $13.0B |
| Total Liabilities | $25.6B | $26.7B | $26.5B | $29.2B | $29.9B |
| Total Equity | $25.0B | $25.1B | $25.7B | $24.2B | $25.5B |
| Retained Earnings | $3.2B | $3.5B | $4.6B | $4.8B | $5.6B |
Cash Flow (Annual)
Last updated: Aug 22, 2026 3:47pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $2.8B | $1.3B | $2.2B | $2.0B |
| Capital Expenditure | -$423.0M | -$353.0M | -$425.0M | -$563.0M | -$486.0M |
| Free Cash Flow | $2.5B | $2.5B | $904.0M | $1.7B | $1.5B |
| Acquisitions (net) | — | $0 | $0 | -$1.0B | -$149.0M |
| Net Debt Issued / (Repaid) | $156.0M | — | $130.0M | $49.0M | $31.0M |
| Dividends Paid | -$955.0M | -$1.1B | -$1.1B | -$1.2B | -$1.3B |
| Stock Buybacks | $0 | -$379.0M | -$706.0M | -$1.1B | -$9.0M |
| Net Change in Cash | — | — | — | — | — |
Growth Trends (YoY %)
Last updated: Aug 22, 2026 3:47pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +10.8% | +5.4% | +3.6% | +8.2% |
| Gross Profit Growth | +5.0% | +10.3% | +5.6% | +5.5% |
| Operating Income Growth | -10.0% | +22.5% | -18.8% | +38.0% |
| Net Income Growth | -33.1% | +51.9% | -33.9% | +44.3% |
| EBITDA Growth | -8.6% | +18.7% | -15.7% | +32.5% |
Dividend History (Last 20)
Last updated: Aug 22, 2026 3:29pm (1d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-26 | $0.23 | — | — | — |
| 2026-03-27 | $0.23 | — | — | — |
| 2026-01-02 | $0.23 | — | — | — |
| 2025-09-26 | $0.23 | — | — | — |
| 2025-06-27 | $0.23 | — | — | — |
| 2025-03-28 | $0.23 | — | — | — |
| 2025-01-03 | $0.23 | — | — | — |
| 2024-09-27 | $0.23 | — | — | — |
| 2024-06-28 | $0.22 | — | — | — |
| 2024-03-27 | $0.22 | — | — | — |
| 2024-01-04 | $0.22 | — | — | — |
| 2023-09-28 | $0.22 | — | — | — |
| 2023-06-29 | $0.20 | — | — | — |
| 2023-03-30 | $0.20 | — | — | — |
| 2023-01-05 | $0.20 | — | — | — |
| 2022-09-29 | $0.20 | — | — | — |
| 2022-06-30 | $0.19 | — | — | — |
| 2022-03-31 | $0.19 | — | — | — |
| 2022-01-05 | $0.19 | — | — | — |
| 2021-09-30 | $0.19 | — | — | — |
Deep Analysis
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-23 02:43Recovery pays +253%; another quarter like the worst recent one costs 53%. Ratio 4.7:1.
| Case | Growth | Margin | Fair value | vs price ($32.04) |
|---|---|---|---|---|
| Bull — recovery | +44% | 17.9% | $112.99 | +253% |
| Base — stabilizes | +29% | 15.6% | $65.73 | +105% |
| Bear — keeps slipping | +15% | 13.2% | $36.20 | +13% |
| Stress — last quarter repeats | +9% | 6.1% | $14.99 | -53% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-22 15:56The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The quarterly revenue trajectory has an obvious tell that the models glossed over: 2026-06-30 revenue of $7.31B against a prior run-rate of ~$4.0-4.5B is not organic acceleration — that's the JDE Peet's acquisition (or similar M&A consolidation) landing on the P&L. Net income of just $142M on $7.31B (1.9% margin) versus 13-15% margins in the four preceding quarters confirms this: deal costs, financing drag, and purchase accounting are compressing earnings. The "revenue accelerating" flag from the secondary signals is mechanically true but analytically misleading. This also explains the $16.14B debt load against $1.03B cash — leverage is climbing precisely as the coffee segment faces green-coffee cost inflation running 40%+ YoY through 2025. Debt/EBITDA on a pro-forma basis is likely pushing 4x, not the benign 0.63 D/E the annual metrics suggest.
The synthesis verdict of $31.99 fair value against $32.04 spot is suspiciously precise and, I think, false precision. The DCF is anchored to trailing FCF of $1.51B, but that FCF number reflects the pre-deal capital structure. Post-deal interest expense on ~$16B+ of debt at 5-6% blended is $850M-$1B annually, which against $2B operating cash flow leaves very thin free cash for the $1.25B dividend commitment (2.87% yield × $43.6B cap = $1.25B). Payout ratio at 60% of GAAP earnings understates the cash strain. The market-forces model correctly flags "overearning in the near term" — 2025's 21.5% operating margin looks like a peak, not a run-rate, given the coffee mix shift and volume softness in CSDs. I'd argue the models collectively underweight this: revenue CAGR of 5.9% and earnings CAGR of *negative* 2.4% over five years is the actual signal, not the noisy 44% recent YoY earnings pop off a -$144M Q4'24 comparable base.
The contrarian bull case worth entertaining: if the acquisition genuinely bolts on $12-14B of annualized coffee revenue at even 15% operating margins, that's $1.8-2.1B incremental EBIT, and the current EV/EBITDA of 14x becomes 10-11x pro-forma — genuinely cheap for a global coffee-and-CSD duopolist. GLP-1 fears are probably overstated for KDP specifically because Dr Pepper's growth has actually accelerated (gaining share vs. Coke/Pepsi) and coffee is orthogonal to weight-loss drug impact. Insider activity is neutral-to-slightly-negative — all option exercises and in-kind tax withholdings, one A-award, zero open-market buys, which for a "steady compounder" narrative is quietly unsupportive. Where I'd push back on the narrative model: calling this "anchored" fundamentals-driven pricing is only true if you accept trailing fundamentals; the market is actually pricing in fairly benign integration, and that's a story, not a cash flow.
My read: KDP is fairly-to-slightly-overvalued at $32, with asymmetric downside if integration disappoints or if 2026 shows the coffee cost cycle isn't rolling over. I dissent partially from the synthesis "fair value" call — I think fair value is closer to $28-30, reflecting a higher discount rate for the leveraged balance sheet and haircut to the peak margin assumption. The 2.87% dividend yield provides a floor but not much cushion given payout stress. I'd want to see two clean post-integration quarters showing operating margin holding above 20% and free cash flow covering the dividend with room before paying above $30. This is not a "buy the dip" name — there's no dip, and the trajectory is decelerating on the metric that matters (earnings). The models over-index on the composite fair-value math and under-index on the balance sheet inflection.
GPT Reading
KDP screens like a classic defensive compounder, but the raw numbers are less serene than that label suggests. The good news is straightforward: revenue has climbed from $12.68B in 2021 to $16.60B in 2025, a 7%ish annualized pace for a supposedly mature beverage business, and 2025 operating income rebounded sharply to $3.58B from $2.59B in 2024. Gross margin at 54.2% and operating margin at 21.5% are strong for packaged beverages, which tells you the brand portfolio still has pricing power and decent mix. At $32, the stock is on about 21x annual earnings, 2.6x sales, and 14.1x EV/EBITDA—hardly distressed, but not obviously expensive for a consumer staple with this margin structure and a 2.9% dividend yield. If I stop at the annuals, I get why the models land around fair value.
What makes me less comfortable with the “steady earner” framing is the quality and consistency of the earnings stream underneath those annual snapshots. Net income has been jumpy: $2.15B in 2021, $1.44B in 2022, $2.18B in 2023, back to $1.44B in 2024, then $2.08B in 2025. Quarterly results are even noisier, with a -$144M quarter in 4Q24 followed by margins mostly in the 13%-16% range through 2025, then a collapse to 6.8% in 1Q26 and just 1.9% in 2Q26 despite revenue surging to $7.31B. A quarter at $7.31B of sales and only $142M of profit is not normal seasonality; that is either a major one-off, a mix shift into much lower-margin business, or a sign that the earnings power implied by trailing P/E is overstated. When a staples stock trades at a full multiple, I want boring quarterly conversion of revenue into cash and earnings. Here, I see a business with solid top-line resilience but questionable near-term earnings quality.
Cash flow also gives me pause. Free cash flow of $1.51B in 2025 against a $43.6B market cap is only about a 3.5% FCF yield, which is thin for a company growing revenue mid-single digits and carrying $16.14B of debt against just $1.03B of cash. Debt-to-equity of 0.63 is not catastrophic, but the balance sheet is not light enough to ignore, especially with a current ratio of 0.64 and a dividend payout ratio around 60%. More importantly, 2025 operating cash flow was only $1.99B versus $2.08B of net income, which is acceptable but not the kind of overwhelming cash conversion that should command a premium multiple in a leveraged staples name. ROIC of 6.8% is fine, not special. Put simply: KDP looks like a decent business, but at $32 the market is paying as if the “defensive” label offsets the combination of leverage, mediocre cash yield, and highly uneven quarterly profitability. My read is slightly bearish: fair value is more like $27-$30 unless the 2026 margin damage proves clearly temporary.
The best case against my view is that I may be overreacting to anomalous quarters and underweighting the longer arc. Revenue momentum is actually respectable: 2025 sales grew to $16.60B from $15.35B, and the recent quarterly run-rate before the 2Q26 spike was healthy—$3.64B, $4.16B, $4.31B, $4.50B, then $3.98B. If 2Q26 includes acquisition or distribution changes that temporarily distort margins, then the market is right to look through it. A 54% gross margin franchise with category-leading brands can often rebuild net margins faster than skeptics expect, and if normalized earnings power is closer to the 2025 level than the weak 2026 first-half print suggests, then 21x earnings is not outrageous. The other bull point is that the stock is not being asked to be a growth darling; it just needs to remain a stable, dividend-paying compounder, and brand durability in soft drinks and single-serve coffee is real. If margins snap back into the low-to-mid teens on a quarterly basis, today’s valuation will look reasonable.
What would change my mind is specific evidence that 2026 is not signaling a structural earnings reset. I’d turn constructive if the next two quarters show revenue ex-spike holding above $4.2B with net margins recovering back above 12%, and if full-year operating cash flow trends comfortably above $2.3B with free cash flow above $1.8B. I’d also want reassurance that debt is not becoming a valuation trap—either through deleveraging or clear interest coverage support from operating income. On the other hand, if revenue stays elevated while net margin remains below 8%, that would confirm the business is buying growth at the expense of profitability, and the stock should trade closer to a mid-teens P/E than 21x.
Grok Reading
The numbers that matter most are the ones breaking the mature-earner script. Fiscal 2025 delivered a clean $16.60B of revenue, $3.58B of operating income, and $2.08B of net income at a 21.5% operating margin and 54% gross margin—respectable staples economics. Then the 2026 run-rate snapped: the June quarter printed $7.31B of revenue (nearly double a normal quarter) against only $142M of net income and a 1.9% net margin, while the March quarter already showed margin compression to 6.8%. Trailing four-quarter net income is roughly $1.43B, which at a $43.6B market cap implies a true TTM P/E closer to 30x, not the 20.9x annual figure that still floats around the tape. Revenue CAGR of 5.9% and a recent 8.2% y/y print look fine until you notice earnings CAGR of –2.4% over the same multi-year window; the company has been buying growth, not compounding it. Free cash flow of $1.51B on $1.99B of operating cash flow is the one bright, high-quality signal, but it sits on $16.14B of total debt, $1.03B of cash, a 0.64 current ratio, and a 6.8% ROIC that barely clears a reasonable WACC. At $32 the stock is pricing a defensive compounder; the ledger is pricing a leveraged consolidator whose incremental dollars are arriving at collapsing margins.
That is the core contradiction with the rule-based “mature earner” label and the fair-value synthesis parked at ~$32. A true mature earner does not post a 15-point swing in quarterly net margin or carry net leverage that leaves interest coverage and refinancing as live risks in a higher-for-longer tape. ROE of 8.2% and ROA of 3.8% are mediocre for a 21–30x earnings multiple in beverages; EV/EBITDA of 14.1x and EV/sales of 3.5x only look reasonable if you assume the 2025 operating margin is the new floor rather than a peak that 2026 is already eroding. The 2.9% dividend yield on a 60% payout is the entire bull case for income mandates, and it is not enough to offset structural GLP-1 and better-for-you volume pressure plus Keurig pod commoditization. Insider activity is pure option exercise and tax withholding—zero open-market conviction. The market narrative layer correctly notes that price tracks DCF almost exactly with negligible story premium; the problem is that the DCF appears to be using smoother, higher-margin earnings than the last two quarters actually delivered.
The strongest case against this read is straightforward and quantitative. Annual 2025 operating income jumped to $3.58B from $2.59B, FCF CAGR of 29% is excellent, and the sudden $7.31B revenue quarter may simply be a closed acquisition whose integration costs and purchase accounting are temporary—once synergies land, the run-rate could re-rate toward the $35–36 composite some models still whisper. Gross margin holding above 54% historically signals real pricing power in Dr Pepper and the broader CSDs, and a 5–6% top-line grower with a fortress brand portfolio has historically cleared 18–20x without drama. If the June margin collapse is one-time and TTM earnings re-accelerate back above $2B, then 21x on restored power and a 3% yield is fair, not rich, especially versus slower pure-play bottlers. I weigh that case as real but incomplete: it requires believing the debt-funded step-up in scale will earn above the cost of capital quickly, and the balance sheet (current ratio 0.64, net debt ~$15B) gives limited room for a multi-year miss while the payout stays at 60%.
What flips the view is concrete: two consecutive quarters of net margin back above 10% on the expanded revenue base, a clear deleveraging path that takes net debt/EBITDA meaningfully lower, or FY2026 free cash flow holding above $1.5B after integration cash outflows. Conversely, another sub-5% net margin quarter or a dividend cut would confirm the over-earning thesis and push fair value into the mid-20s.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
KDP is a classic mature earner: revenue up steadily from $12.68B in 2021 to $16.60B in 2025 (roughly 7% CAGR), gross margin stable in the 52-56% range, and operating margin oscillating 17-23% depending on year (2024 dip to 16.9% is the notable soft spot). Net income has bounced $1.44B-$2.18B; FCF is durably positive at $0.9B-$2.5B, averaging around $1.8B. OCF/NI at 1.28x and accruals at -0.8% of assets indicate clean earnings; Beneish M of -2.36 shows no manipulation flags. Per-share value is being concentrated: diluted shares fell from 1.43B to 1.36B (-1.2% CAGR), and buybacks run nearly 5x SBC, so dilution is not a concern. The real constraint is leverage. Net debt of roughly $15.1B against $1.51B FCF implies about 10x FCF to pay down debt, and short-term debt of $3.11B exceeds $1.03B of liquid cash - refinancing is a recurring exercise, not optional. Altman Z of 1.46 flags 'distress' but the Z-score is poorly calibrated for consumer staples with heavy goodwill/intangibles from the 2018 Keurig-Dr Pepper merger; the more relevant read is that leverage is meaningful but serviced comfortably by predictable FCF. Insider tape is all routine option exercises and tax withholdings plus one award - no directional buys or sales. Nothing informative either way. The business itself is a durable branded-beverage franchise (Dr Pepper, Snapple, coffee pods, recent energy/hydration expansion) with pricing power evidenced by stable gross margins through the 2022-2024 inflation cycle.
Verify before trusting this (6)
- Debt maturity ladder and weighted-average cost - how much of the $3.11B short-term debt is commercial paper vs term notes
- Segment-level margin trend (U.S. Refreshment Beverages vs Coffee vs International) to source the 2024 OpM dip
- Working capital drivers behind the 2023 FCF drop to $904M
- Goodwill/intangible balance from the 2018 merger and any impairment testing sensitivity
- Recent M&A (Ghost, Electrolit, La Colombe) and integration/capital commitment implications
- Customer/channel concentration in coffee pod business given category softness
The valuation triangulation is unusually tight around today's price. Composite FV is $35.92 and the signal-adjusted FV is $31.99 versus a spot price of $32.04 - essentially zero margin of safety in either direction. The methods bracket sensibly: DCF at $45.82 flatters a mature, levered compounder with terminal-value optimism, EPV floor at $22.18 says the no-growth downside is real given $15B net debt, and the anchored P/E at $29.86 lands closest to price. Averaging skeptically toward the earnings-power and multiple anchors (which respect the leverage) puts deserved value in the low-$30s. That is where it trades. Earnings quality is good, so no haircut is warranted, but neither is a premium - the market already knows this is a solid staples name. The bull case (pricing power, buybacks) is priced in; the bear case (Keurig commoditization, health-driven volume erosion, debt service) is not deeply discounted either. For a Solid-but-levered business with mid-single-digit growth, paying deserved value is exactly what you would expect. There is no gap to exploit here - the edge would only appear on a meaningful drawdown that opens a real discount to the anchored P/E and earnings-power floor.
Verify before trusting this (4)
- Forward volume trends in CSD and single-serve coffee to test the Keurig commoditization thesis
- Net debt trajectory and refinancing schedule at current rates
- Pricing versus volume mix in the next few quarters to confirm elasticity
- Capital allocation split between buybacks, dividend, and deleveraging
KDP is the textbook 'no-narrative' stock right now. The archetype is steady-compounder with minimal intensity and low cult coefficient, and the fundamentals-vs-story gap is essentially zero (+0.2%), meaning the market is neither paying a premium for the brand moat nor discounting secular decline. There is simply no active story pushing this name up or down. Analyst and press flow is sparse and mixed: one constructive Zacks-style piece on the energy portfolio potentially offsetting coffee softness, no target revisions of note, no upgrade/downgrade in the batch. That is a mild, ambient positive but nothing that moves the tape. On the macro side, the regime is modestly risk-on (+32) with a low VIX of 15.1, which is typically a slight relative headwind for low-beta defensives like KDP (beta 0.41) since capital rotates toward higher-beta risk assets. But offsetting that, the 10y at 4.69% and a stretched market PE of 25.7 create a bid for reliable-cash-flow defensives whenever the tape wobbles - and the S&P is already 1.6% off its high with the regime only 1 day old. Net: KDP sits in a narrative vacuum, its low beta insulates it from the risk-on rotation cost, and the news flow is neutral-to-slightly-constructive. The non-fundamental pressure is close to zero, leaning a hair negative from rotation-away-from-defensives risk.
Verify before trusting this (5)
- Whether the energy-portfolio angle gets picked up by sell-side as a genuine growth catalyst or stays a footnote
- Any sign the risk-on regime extends past a few days, which would deepen the rotation-away-from-defensives cost
- KO or PEP earnings reactions - a peer de-rating on FX or volume weakness could either drag KDP or make it the relative winner
- Analyst target revisions - none in the batch, so the first mover sets tone
- Sustained VIX under 14 would confirm the risk-on rotation and weigh more on low-beta names
A mature, inelastic North American beverage category where the growth question is settled by share and pricing, not by demand. Two forces dominate KDP's forward path: coffee commodity inflation and tariff exposure on green coffee (a direct hit to the single-serve system's economics), and a 4.69% long rate that makes debt-funded consolidation expensive. Consumers are drifting toward zero-sugar, functional and energy formats — KDP is positioned on the right side of that in refreshment beverages and the wrong side in pods. The strategic reshaping (large coffee consolidation, with a separation of coffee from refreshment on the table) means the reported growth series for the next several quarters describes corporate structure, not business demand. An analyst who confuses the two will overstate the run-rate badly.
When we made this prediction on Aug 23, 2026, KDP was $32.04. We expect it to be $34.50 by Feb 2027, and we consider it great value under $27.50. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 23, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.